All In Biotech

Drug Trial Radar · NCT06937931

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

A Phase II, Multicentre, Randomised, Double-blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of IPN10200 as a Treatment for Cervical Dystonia in Adult Participants

Last checked: Nov 19, 2026Latest source record: Sep 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 132 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

132

Planned (sponsor's estimate)

Start

Jun 30, 2025

Primary completion

Mar 26, 2027

Study completion Nov 5, 2027

Sponsor

Lead sponsor
IpsenIndustry
Sponsor type
Industry
First posted
Apr 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of the study drug, Corabotase (also known as IPN10200), and to assess how well it works when compared with placebo in treating Cervical Dystonia (CD) in adults. CD can cause a series of abnormalities and symptoms in the head and neck that can lead to neck pain and stiffness, and headaches. CD is believed to involve deep parts within the brain that control movement, but genetic factors, environmental factors, and abnormalities in the brain may also play a role. The usual treatment for CD includes injecting BoNT into the affected muscles, but the treatment only lasts about 3 months. Corabotase is designed to last for a longer period. The study will consist of two periods: 1. A Screening Period of up to 4 weeks (28 days) to assess whether a participant can take part in the study and requires at least one visit. 2. A Treatment Period of 36 weeks. On Day 1 of the treatment period, participants will receive either Corabotase Dose A or Dose B (additional participants may receive Corabotase Dose C) of the study drug, or placebo distributed into different muscles in the head, neck and shoulders. Participants may continue some other medications, but details need to be recorded. There will be 10 visits to the clinic in person and one remote visits (phone call) (12 visits to the clinic for participants who receive Dose C). Participants will undergo blood samplings, urine collections, physical/neurological examinations, and clinical evaluations. Participants will also need to complete questionnaires throughout the study. The total study duration for a participant will be up to 40 weeks (approximately 9 months).

Conditions

  • Cervical Dystonia

Interventions

  • CorabotaseBiological

    Study intervention will be administered in a single treatment cycle after randomisation (Day 1). The administration cycle consists of intramuscular injection.

  • PlaceboOther

    Excipients without active substance will be administered in a single treatment cycle after randomisation (Day 1). The administration cycle consists of intramuscular injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) total scoreTime frame: At Week 4

Locations

45 sites in 8 countries. Site status is shown where the registry gives one.

  • University of Arizona Health Sciences - Neurology

    Tucson, Arizona · Active not recruiting

  • Parkinson's & Mvmt Disorders Inst

    Fountain Valley, California · Recruiting

  • Loma Linda University School of Medicine - Neurology

    Loma Linda, California · Withdrawn

  • Parkinson's Ds & Mvt Disorders Cntr

    Boca Raton, Florida · Recruiting

  • USF Health Byrd Alzheimer's Institute

    Tampa, Florida · Not yet recruiting

  • Emory Brain Health Center

    Atlanta, Georgia · Recruiting

  • Rush Medical Center

    Chicago, Illinois · Recruiting

  • Quest Research Institute

    Farmington Hills, Michigan · Recruiting

  • Ichan Sch of Medicine @ Mt. Sinai

    New York, New York · Recruiting

  • Kingfisher Cooperative

    Spokane, Washington · Recruiting

  • Fakultni nemocnice u sv. Anny v Brne - I. Neurologicka klinika

    Brno, Czechia · Recruiting

  • MINKSneuro s.r.o.

    Brno, Czechia · Active not recruiting

  • NEUROHK s.r.o.

    Choceň, Czechia · Recruiting

  • Fakultni nemocnice Olomouc - Neurologicka klinika

    Olomouc, Czechia · Not yet recruiting

  • Vseobecna fakultni nemocnice v Praze - Neurologicka klinika

    Prague, Czechia · Withdrawn

  • CHU Grenoble Alpes - Site Nord - Neurology

    Grenoble, France · Recruiting

  • Timone University Hospital

    Marseille, France · Active not recruiting

  • CHU Nimes - Hôpital Caremeau

    Nîmes, France · Recruiting

  • Hopitaux Universitaire de Strasbourg - Hopital de Hautepierre - Neurologie

    Strasbourg, France · Active not recruiting

  • Centre Hospitalier Universitaire (CHU) Purpan - Institut Des Sciences du Cerveau De Toulouse (Institute for Brain Sciences)

    Toulouse, France · Recruiting

  • Curiositas ad sanum Studien- und Beratungs GmbH Haag i.OB - Neurologie

    Haag in Oberbayern, Germany · Recruiting

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, Germany · Not yet recruiting

  • GFO Kliniken Troisdorf

    Troisdorf, Germany · Recruiting

  • University Hospital Tuebingen - Neurologie

    Tübingen, Germany · Active not recruiting

  • Ospedale Bellaria, IRCCS Istituto delle Scienze Neurologiche, AUSL Bologna

    Bologna, Italy · Recruiting

  • Istituto Auxologico Italiano - Auxologico San Luca

    Milan, Italy · Recruiting

  • Istituto Neurologico C. Besta

    Milan, Italy · Active not recruiting

  • IRCCS C.Mondino, Istituto Neurologico Nazionale, Fondazione

    Pavia, Italy · Recruiting

  • Azienda USL-IRCCS di Reggio Emilia - Presidio ospedaliero provinciale sede di Reggio Emilia

    Reggio Emilia, Italy · Not yet recruiting

  • Specjalistyczna Praktyka Lekarska Dr Stanislaw Ochudlo

    Katowice, Poland · Withdrawn

  • Futuremeds Krakow

    Krakow, Poland · Recruiting

  • SP ZOZ Szpital Uniwersytecki w Krakowie

    Krakow, Poland · Recruiting

  • Instytut Zdrowia Dr Boczarska-Jedynak Sp. z o.o. S.K.

    Oświęcim, Poland · Recruiting

  • Eskulap Pabianice Sp z o.o.

    Pabianice, Poland · Recruiting

  • ETG Neuroscience Sp. z o.o.

    Warsaw, Poland · Recruiting

  • Wojewodzki Szpital Specjalistyczny im. J. Gromkowskiego

    Wroclaw, Poland · Withdrawn

  • Hospital de la Santa Creu i Sant Pau - Neurología

    Barcelona, Spain · Active not recruiting

  • H.U. Puerta del Mar - Neurocirugía

    Cadiz, Spain · Recruiting

  • Hospital Universitario De La Princesa

    Madrid, Spain · Recruiting

  • Hospital Universitario Ramon y Cajal - Neurologia

    Madrid, Spain · Withdrawn

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.